GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:190332012 | Liver | Cirrhotic | regulation of protein modification by small protein conjugation or removal | 105/4634 | 242/18723 | 1.43e-10 | 7.43e-09 | 105 |
GO:00510546 | Liver | Cirrhotic | positive regulation of DNA metabolic process | 73/4634 | 201/18723 | 1.60e-04 | 1.52e-03 | 73 |
GO:00705553 | Liver | Cirrhotic | response to interleukin-1 | 52/4634 | 143/18723 | 1.27e-03 | 8.54e-03 | 52 |
GO:005105211 | Liver | Cirrhotic | regulation of DNA metabolic process | 114/4634 | 359/18723 | 1.48e-03 | 9.85e-03 | 114 |
GO:00900853 | Liver | Cirrhotic | regulation of protein deubiquitination | 8/4634 | 12/18723 | 2.59e-03 | 1.53e-02 | 8 |
GO:0071347 | Liver | Cirrhotic | cellular response to interleukin-1 | 41/4634 | 113/18723 | 4.08e-03 | 2.19e-02 | 41 |
GO:190332022 | Liver | HCC | regulation of protein modification by small protein conjugation or removal | 167/7958 | 242/18723 | 4.99e-17 | 4.72e-15 | 167 |
GO:00022211 | Liver | HCC | pattern recognition receptor signaling pathway | 107/7958 | 172/18723 | 1.37e-07 | 2.58e-06 | 107 |
GO:005105221 | Liver | HCC | regulation of DNA metabolic process | 198/7958 | 359/18723 | 7.62e-07 | 1.17e-05 | 198 |
GO:005105411 | Liver | HCC | positive regulation of DNA metabolic process | 113/7958 | 201/18723 | 5.76e-05 | 5.33e-04 | 113 |
GO:00706461 | Liver | HCC | protein modification by small protein removal | 91/7958 | 157/18723 | 6.50e-05 | 5.92e-04 | 91 |
GO:009008511 | Liver | HCC | regulation of protein deubiquitination | 11/7958 | 12/18723 | 5.97e-04 | 3.75e-03 | 11 |
GO:00705551 | Liver | HCC | response to interleukin-1 | 80/7958 | 143/18723 | 7.95e-04 | 4.77e-03 | 80 |
GO:00165791 | Liver | HCC | protein deubiquitination | 78/7958 | 139/18723 | 8.13e-04 | 4.87e-03 | 78 |
GO:00705361 | Liver | HCC | protein K63-linked deubiquitination | 24/7958 | 35/18723 | 1.64e-03 | 8.61e-03 | 24 |
GO:0002224 | Liver | HCC | toll-like receptor signaling pathway | 67/7958 | 121/18723 | 2.87e-03 | 1.34e-02 | 67 |
GO:00622072 | Liver | HCC | regulation of pattern recognition receptor signaling pathway | 59/7958 | 105/18723 | 3.18e-03 | 1.47e-02 | 59 |
GO:00711081 | Liver | HCC | protein K48-linked deubiquitination | 23/7958 | 35/18723 | 4.72e-03 | 2.02e-02 | 23 |
GO:00713471 | Liver | HCC | cellular response to interleukin-1 | 61/7958 | 113/18723 | 8.98e-03 | 3.46e-02 | 61 |
GO:190332020 | Oral cavity | OSCC | regulation of protein modification by small protein conjugation or removal | 165/7305 | 242/18723 | 2.52e-20 | 3.99e-18 | 165 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
OTUD4 | SNV | Missense_Mutation | | c.151G>T | p.Asp51Tyr | p.D51Y | Q01804 | protein_coding | deleterious(0.01) | probably_damaging(0.988) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
OTUD4 | SNV | Missense_Mutation | | c.2777N>C | p.Lys926Thr | p.K926T | Q01804 | protein_coding | tolerated(0.11) | possibly_damaging(0.787) | TCGA-B5-A11N-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
OTUD4 | SNV | Missense_Mutation | rs762042941 | c.2600C>T | p.Pro867Leu | p.P867L | Q01804 | protein_coding | tolerated(0.11) | benign(0) | TCGA-B5-A11U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
OTUD4 | SNV | Missense_Mutation | novel | c.1385G>T | p.Arg462Ile | p.R462I | Q01804 | protein_coding | deleterious(0) | benign(0) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
OTUD4 | SNV | Missense_Mutation | rs768825820 | c.944G>A | p.Arg315Gln | p.R315Q | Q01804 | protein_coding | deleterious(0.02) | probably_damaging(0.914) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
OTUD4 | SNV | Missense_Mutation | | c.1082G>A | p.Arg361Lys | p.R361K | Q01804 | protein_coding | tolerated(0.15) | probably_damaging(0.969) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
OTUD4 | SNV | Missense_Mutation | novel | c.2925N>T | p.Lys975Asn | p.K975N | Q01804 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-B5-A5OC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | cisplatin | SD |
OTUD4 | SNV | Missense_Mutation | rs763657706 | c.1340G>A | p.Arg447Gln | p.R447Q | Q01804 | protein_coding | tolerated(0.57) | benign(0.015) | TCGA-BK-A6W3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
OTUD4 | SNV | Missense_Mutation | rs370178922 | c.1109G>A | p.Arg370Gln | p.R370Q | Q01804 | protein_coding | deleterious(0.02) | probably_damaging(0.996) | TCGA-BK-A6W3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
OTUD4 | SNV | Missense_Mutation | | c.919A>C | p.Lys307Gln | p.K307Q | Q01804 | protein_coding | deleterious(0.01) | probably_damaging(0.996) | TCGA-BS-A0TC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |